China In-Focus: Winner Medical Raises $8.4 Million

May 3, 2010 (FinancialWire) — Winner Medical Group Inc. (NASDAQ: WWIN), a manufacturer of medical dressings, medical disposables and non-woven PurCotton materials for the medical and consumer products industries, said that it has closed a public offering of 1.38 million shares of common stock, receiving around $8 million in net proceeds.

Winner said it plans to use the funds to expand the production capacity of its PurCotton product line and for general corporate and working capital purposes.

China-based Winner Medical is a manufacturer and exporter in the medical dressing industry in China. The firm has eight wholly-owned operating subsidiaries and four joint ventures with over 5,000 employees.

Winner engages in the manufacturing, sale, research and development of medical care products, wound care products, home care products and PurCotton products, a nonwoven fabric made from 100% natural cotton.

Streaming Research for all companies mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate, courtesy of Stock Smart (at

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate ( written by FIRST Research Consortium ( member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website ( Contact FinancialWire(tm) directly via

Comments are closed.